YAP1 and hepatocellular carcinoma: Liu et al. revealed that hypoxia-conditioned mesenchymal stem cells (hypo-MSCs) enhance HCC progression via the COX2/PGE2/EP4 axis, activating YAP and driving proliferation through the AKT/mTOR/SREBP1 pathway.